MONROVIA/DAKAR (Reuters) - U.S. authorities have approved a request from Liberia's government to send sample doses of the experimental ZMapp drug to treat Liberian doctors infected with Ebola, the Liberian presidency said.
A statement on the Liberian presidency's website said the drug would be delivered to the West African country this week by a U.S. government representative.
